PubRank

Use of urate-lowering therapies is not associated with an increase in the risk of incident dementia in older adults.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28970216)

Published in Ann Rheum Dis on September 26, 2017

Authors

Jasvinder A Singh1,2,3, John D Cleveland4

Author Affiliations

1: Medicine Service, Birmingham VA Medical Center, Birmingham, AL.
2: Department of Medicine at School of Medicine, and Division of Epidemiology at School of Public Health, University of Alabama at Birmingham (UAB), Birmingham, AL.
3: Department of Orthopedic Surgery, Mayo Clinic College of Medicine, Rochester, MN.
4: Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.

Articles by these authors ⇆

Role of serum urate in neurocognitive function and dementia: new evidence contradicts old thinking. Ann Rheum Dis (2017) 0.75

The burden of septic arthritis on the U.S. inpatient care: A national study. PLoS One (2017) 0.75

Are the days of missed or delayed diagnosis of gout over? Nat Rev Rheumatol (2019) 0.75

Response to: 'A response to Singh. "Lesinurad combination therapy with allopurinol in gout: do CLEAR studies make the treatment of gout clearer?"' by Valiyil and Schechter. Ann Rheum Dis (2017) 0.75

Septic arthritis in the Emergency Departments in the U.S.: A National Study of healthcare utilization and time-trends. Arthritis Care Res (Hoboken) (2017) 0.75